辅酶Ⅰ体内代谢调控研究进展

doi:10.19586/j.2095-2341.2021.0085

生物技术进展 ›› 2021, Vol. 11 ›› Issue (4): 526-534.DOI: 10.19586/j.2095-2341.2021.0085

辅酶Ⅰ体内代谢调控研究进展

孙卉(), 张春义, 姜凌()

中国农业科学院生物技术研究所，北京 100081

收稿日期:2021-05-17 接受日期:2021-06-21 出版日期:2021-07-25 发布日期:2021-08-02
通讯作者: 姜凌
作者简介:孙卉 E-mail：sunhui@caas.cn；
基金资助:
国家自然科学基金项目(31870283);中国农业科学院创新工程项目(SWJSZD2020-001)

Research Progress on Regulation of Coenzyme Ⅰ Metabolism

Hui SUN(), Chunyi ZHANG, Ling JIANG()

Biotechnology Research Institute，Chinese Academy of Agricultural Sciences，Beijing 100081，China

Received:2021-05-17 Accepted:2021-06-21 Online:2021-07-25 Published:2021-08-02
Contact: Ling JIANG

摘要/Abstract

摘要：

辅酶Ⅰ——烟酰胺腺嘌呤二核苷酸（nicotinamide adenine dinucleotide，NAD⁺）是一种在糖酵解、糖异生、三羧酸循环及呼吸链中发挥重要作用的辅酶，广泛参与DNA修复、组蛋白去乙酰化等生命过程。近年来研究表明NAD⁺合成的前体和中间化合物（具有维生素B3活性的烟酸、烟酰胺、烟酰胺核苷和烟酰胺单核苷酸）在预防糙皮病、延缓衰老,治疗神经和心血管多种疾病、调节胰岛素分泌、调控mRNA的表达等方面具有重要疗效。着重介绍了辅酶Ⅰ体内的合成代谢以及参与的调节衰老进程，以期为利用合成生物学技术在大肠杆菌中富集NAD⁺中间化合物提供理论依据和技术支撑。

关键词: 辅酶Ⅰ, 烟酰胺腺嘌呤二核苷酸, 合成代谢, 人体, 衰老, 调控

Abstract:

Nicotinamide adenine dinucleotide （NAD⁺） is a coenzyme that plays an important role in glycolysis， gluconeogenesis， tricarboxylic acid cycle and respiratory chain. It is widely involved in DNA repair， histone deacetylation and other life processes. In recent years， studies have shown that NAD⁺ substrates and intermediates （molecules with vitamin B3 activity， such as nicotinic acid， nicotinamide， nicotinamide nucleoside and nicotinamide mononucleotide） have many important effects on taking precautions against pellagra， delaying aging， curing diseases such as nerve and cardiovascular diseases， regulating insulin secretion， regulating mRNA expression and so on. This paper reviewed the synthesis and metabolism of coenzyme and the regulation of coenzyme metabolism during the aging process， and provided a theoretical basis and technical support for the enrichment of NAD⁺ intermediates in Escherichia coli and other organisms by synthetic biology.

Key words: coenzyme Ⅰ, NAD⁺, synthesis and metabolism, human, aging, regulation

中图分类号:

Q552

孙卉, 张春义, 姜凌. 辅酶Ⅰ体内代谢调控研究进展[J]. 生物技术进展, 2021, 11(4): 526-534.

Hui SUN, Chunyi ZHANG, Ling JIANG. Research Progress on Regulation of Coenzyme Ⅰ Metabolism[J]. Current Biotechnology, 2021, 11(4): 526-534.

图/表 4

图1 辅酶Ⅰ及其前体和中间化合物的化学结构式及相互转化关系

Fig. 1 Chemical structures and interconversion of coenzyme Ⅰ and its precursor and intermediate product

图2 体内NAD+的合成途径

Fig.2 NAD+ synthetic pathway in living body

图3 NAD+参与的生命过程

Fig.3 Life processes that NAD+ participates in

图4 衰老过程中调控NAD+平衡的分子机制

Fig. 4 Molecular mechanisms that balancing NAD+ during aging

参考文献 48

1	HEGYI J, SCHWARTZ R A, HEGYI V. Pellagra: dermatitis, dementia, and diarrhea [J]. Int. J. Dermatol., 2004, 43(1):1-5.
2	HONG W, MO F, ZHANG Z, et al.. Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by targeting NAD⁺ metabolism [J/OL]. Front. Cell Dev. Biol., 2020, 8:246[2021-06-25]. .
3	CANTÓ C, MENZIES K J, AUWERX J. NAD⁺ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus [J]. Cell Metab., 2015, 22(1):31-53.
4	ANDERSON K A, MADSEN A S, OLSEN C A, et al.. Metabolic control by sirtuins and other enzymes that sense NAD⁺, NADH, or their ratio [J]. Biochim. Biophys. Acta., 2017, 1858(12):991-998.
5	YAKU K, OKABE K, NAKAGA W A. NAD metabolism: implications in aging and longevity [J]. Age. Res. Rev., 2018,47:1-17.
6	KIRKLAND J B, MEYER-FICCA M. Niacin [J]. Adv. Food. Nutr. Res., 2018, 83:83-149.
7	BIEGANOWSKI P, BRENNER C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD⁺ in fungi and humans [J]. Cell, 2004, 117:495-502.
8	YANG Y, SAUVE A A. NAD⁺ metabolism: bioenergetics, signaling and manipulation for therapy [J]. Biochim. Biophys. Acta., 2016, 1864:1787-1800.
9	BADAWY A A. Kynurenine pathway of tryptophan metabolism: Regulatory and functional aspects [J]. Int. J. Tryptophan Res., 2017, 10:1-10.
10	FUKUWATARI T, SUGIMOTO E, SHIBATA K. Growth-promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of ACMSD activity [J]. Biosci. Biotechnol. Biochem., 2002, 66(7):1435-1441.
11	FELDBLUM S, ROUGIER A, LOISEAU H, et al.. Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue [J]. Epilepsia, 1988, 29(5):523-529.
12	PREISS J, HANDLER P. Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates [J]. J. Biol. Chem., 1958, 233:488-492.
13	CONFORTI L, JANECKOVA L, WAGNER D, et al.. Reducing expression of NAD⁺ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration [J]. FEBS. J., 2011, 278:2666-2679.
14	GILLEY J, ADALBERT R, YU G, et al.. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2 [J]. J. Neurosci., 2013, 33:13410-13424.
15	VANLINDEN M R, DOLLE C, PETTERSEN I K, et al.. Subcellular distribution of NAD⁺ between cytosol and mitochondria determines the metabolic profile of human cells [J]. J. Biol. Chem., 2015, 290:27644-27659.
16	BERGER F, LAU C, DAHLMANN M, et al.. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms [J]. J. Biol. Chem., 2005, 280:36334-36341.
17	GROZIO A, MILLS K F, YOSHINO J, et al.. Slc12a8 is a nicotinamide mononucleotide transporter [J]. Nat. Metab., 2019, 1:47-57.
18	NAKAHATA Y, SAHAR S, ASTARITA G, et al.. Circadian control of the NAD⁺ salvage pathway by CLOCK-SIRT1 [J]. Science, 2009, 324:654-657.
19	REVOLLO J R, KORNER A, MILLS K F, et al.. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme [J]. Cell. Metab., 2007, 6:363-375.
20	YOON M J, YOSHIDA M, JOHNSON S, et al.. SIRT1-Mediated eNAMPT secretion from adipose tissue regulates hypothalamic NAD⁺ and function in mice [J]. Cell Metab., 2015, 21:706-717.
21	WANG B, HASAN M K, ALVARADO E, et al.. NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response [J]. Oncogene, 2011, 30:907-921.
22	FANG E F, KASSAHUN H, CROTEAU D L, et al.. NAD⁺replenishment improves lifespan and healthspan in Ataxia telangiectasia models via mitophagy and DNA repair [J]. Cell. Metab., 2016, 24:566-581.
23	KLIMOVA N, FEARNOW A, LONG A, et al.. NAD⁺ precursor modulates post-ischemic mitochondrial fragmentation and reactive oxygen species generation via SIRT3 dependent mechanisms [J/OL]. Exp. Neurol., 2020, 325:113144[2021-06-25]. .
24	WAKADE C, CHONG R, BRADLEY E, et al.. Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects [J]. Clin. Case. Rep., 2015, 3(7):635-637.
25	ZHAO C, LI W, DUAN H, et al.. NAD⁺ precursors protect corneal endothelial cells from UVB-induced apoptosis [J]. Am. J. Physiol. Cell Physiol., 2020, 318:C796-C805.
26	YAMAMOTO T, BYUN J, ZHAI P, et al.. Nicotinamide mononucleotide, an intermediate of NAD⁺ synthesis, protects the heart from ischemia and reperfusion [J/OL]. PLoS ONE, 2014, 9:e98972[2021-06-25]. .
27	DE PICCIOTTO N E, GANO L B, JOHNSON L C, et al.. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice [J]. Aging Cell, 2016,15:522-530.
28	ASSIRI M A, ALI H R, MARENTETTE J O, et al.. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease [J/OL]. Hum. Genomics, 2019, 13:65[2021-06-25]. .
29	MORIGI M, PERICO L, ROTA C, et al.. Sirtuin3-dependent mitochondrial dynamic improvements protect against acute kidney injury [J]. J. Clin. Invest., 2015,125:715-726.
30	CHEN Y, LIANG Y, HU T, et al.. Endogenous Nampt upregulation is associated with diabetic nephropathy inflammatory-fibrosis through the NF-κBp65 and Sirt1 pathway; NMN alleviates diabetic nephropathy inflammatory-fibrosis by inhibiting endogenous Nampt [J]. Exp. Ther. Med., 2017,14:4181-4193.
31	CHOI S E, FU T, SEOK S, et al.. Elevated microRNA-34a in obesity reduces NAD⁺ levels and SIRT1 activity by directly targeting NAMPT[J]. Aging Cell, 2013,12:1062-1072.
32	BENAVENTE C A, SCHNELL S A, JACOBSON E L. Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin [J/OL]. PLoS ONE, 2012, 7(7):e4227[2021-06-25]. .
33	FREDERICK D W, LORO E, LIU L, et al.. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle [J]. Cell Metab., 2016, 24:269-282.
34	IMAI S, GUARENTE L. It takes two to tango: NAD⁺ and sirtuins in aging/longevity control [J/OL]. NPJ Aging Mech. Dis., 2016, 2(1):16017[2021-06-25]. .
35	CAMACHO-PEREIRA J, TARRAGO M G, CHINI C C S, et al.. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism [J]. Cell Metab., 2016, 23:1127-1139.
36	MASSUDI H, GRANT R, BRAIDY N, et al.. Age-associated changes in oxidative stress and NAD⁺ metabolism in human tissue [J/OL]. PLoS ONE, 2012, 7(7):e42357[2021-06-25]. .
37	KIM M Y, ZHANG T, KRAUS W L. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD⁺ into a nuclear signal [J]. Genes Dev., 2005, 19:1951-1967.
38	PALAZZO L, MIKOČ A, AHEL I. ADP-ribosylation: New facets of an ancient modification [J]. FEBS J., 2017, 284:2932-2946.
39	MALAVASI F, DEAGLIO S, FUNARO A, et al.. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology [J]. Physiol. Rev., 2008, 88:841-886.
40	ESCANDE C, NIN V, PRICE N L, et al.. Flavonoid apigenin is an inhibitor of the NAD⁺ase CD38: implications for cellular NAD⁺ metabolism, protein acetylation, and treatment of metabolic syndrome [J]. Diabetes, 2013, 62(4):1084-1093.
41	PEEK C B, AFFINATI A H, RAMSEY K M, et al.. Circadian clock NAD⁺ cycle drives mitochondrial oxidative metabolism in mice [J/OL]. Science, 2013, 342(6158):1243417[2021-06-25]. .
42	YAMADA Y, ARAI T, SUGAWARA S, et al.. Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma [J]. Cancer Sci., 2018, 109:1239-1253.
43	MICHAN S, SINCLAIR D. Sirtuins in mammals: Insights into their biological function [J]. Biochem. J., 2007, 404(1):1-13.
44	GOLDIE C, TAYLOR A J, NGUYEN P, et al.. Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomized controlled trials [J]. Heart, 2015, 102:198-203.
45	RAJMAN L, CHWALEK K, SINCLAIR D A. Therapeutic potential of NAD-Boosting molecules: the in vivo evidence [J]. Cell Metab., 2018, 27:529-547.
46	WANG G, HAN T, NIJHAWAN D, et al.. P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage [J]. Cell, 2014, 158:1324-1334.
47	SHOJI S, YAMAJI T, MAKINO H, et al.. Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide[J]. Metab. Eng., 2021, 65:167-177.
48	DING Y, LI X, HORSMAN G P, et al.. Construction of an alternative NAD⁺ de novo biosynthesis pathway[J/OL]. Adv. Sci., 2021, 8(9):2004632[2021-06-25]. .

[1]	曹丹, 马林龙, 刘艳丽, 王丽丽, 金孝芳. 植物营养元素胁迫相关microRNA研究进展[J]. 生物技术进展, 2022, 12(6): 801-805.
[2]	杜开颜, 祁晨旭, 曹静钰, 陈蒙, 高静, 刘承梅. 铁死亡参与脊髓损伤调控的研究进展[J]. 生物技术进展, 2022, 12(6): 869-874.
[3]	吴一凡, 林晟豪, 许文涛. 小分子靶标的核糖开关生物传感器研究进展[J]. 生物技术进展, 2022, 12(2): 168-175.
[4]	王欣, 张天柱. 园艺作物花青素合成调控研究进展[J]. 生物技术进展, 2022, 12(1): 10-16.
[5]	王婉洁, 陈南珠, 郝海生, 赵学明, 朱化彬, 杜卫华. 组蛋白甲基转移酶ASH2的研究进展[J]. 生物技术进展, 2022, 12(1): 27-35.
[6]	张卡, 王泳浩, 吴云峰, 许雷, 王海胜. 苜蓿中华根瘤菌氮代谢调控相关非编码RNA的研究[J]. 生物技术进展, 2022, 12(1): 90-98.
[7]	孙卉,张春义,姜凌. 马铃薯维生素代谢研究应用进展[J]. 生物技术进展, 2020, 10(4): 351-357.
[8]	邢利娟，刘悦萍，王磊，徐妙云. miRNA参与植物胚和胚乳发育调控的研究进展[J]. 生物技术进展, 2020, 10(2): 109-116.
[9]	黄春蒙,,朱鹏宇,王智,王晨光,杜智欣,魏霜4,张永江,付伟. 基于RNAi技术的转基因植物监管现状及其面临的育种领域的挑战[J]. 生物技术进展, 2020, 10(1): 10-14.
[10]	张在宝,,赵海,胡梦辉,邓丽君,王琦,李九丽,袁红雨,. 组学在花药发育研究中的应用进展Ⅰ:转录组学[J]. 生物技术进展, 2019, 9(5): 433-439.
[11]	林晶晶,杨宇丰. 线粒体自噬的调控机制及其在相关疾病中的作用[J]. 生物技术进展, 2019, 9(5): 467-475.
[12]	丁珊,任禹静,姜凌,梅子青. 磷酸化对UCHL3体外去泛素化酶活性的影响[J]. 生物技术进展, 2019, 9(5): 527-535.
[13]	闫东科,吕平. 低氧诱导因子及其抑制剂研究进展[J]. 生物技术进展, 2019, 9(4): 332-340.
[14]	褚蔚,刘洋洋,李永波,楚秀生. 植物3-羟基-3-甲基戊二酰辅酶A还原酶基因研究进展[J]. 生物技术进展, 2018, 8(2): 93-102.
[15]	秦海波,朱建明. 中国典型高硒区硒的环境地球化学研究进展[J]. 生物技术进展, 2017, 7(5): 367-373.

辅酶Ⅰ体内代谢调控研究进展

Research Progress on Regulation of Coenzyme Ⅰ Metabolism

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 48

相关文章 15

编辑推荐

Metrics

本文评价